We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 12 start-ups with an aggregate funding of $967.7m. The average funding per company in this subset is $80.6m.
Last update to the database: Mar 17, 2026. See changelog.
1
Funding Rounds
$14.0m
Money raised
QureBio is a Shanghai-based biopharmaceutical company developing bispecific and multispecific antibody therapies targeting cancer, autoimmune, and inflammatory diseases. Founded by Dr. Xiangdong Qu, it partners with global biotech firms and has raised significant funding, including a ¥100M Series C1 round in 2025.
1
Funding Rounds
$130.0m
Money raised
Angitia is a Westlake Village, California-based company founded by Hua Zhu Ke.
1
Funding Rounds
$21.0m
Money raised
AeroRx Therapeutics is a La Jolla-based company founded by Ahmet Tutuncu.
1
Funding Rounds
$12.7m
Money raised
Accipiter Biosciences is a Seattle-based company founded by Javier Castellanos.
1
Funding Rounds
$32.0m
Money raised
T-Therapeutics is a United Kingdom-based company.
1
Funding Rounds
$160.0m
Money raised
Alveus Therapeutics is a Philadelphia-based company.
1
Funding Rounds
$112.5m
Money raised
Caldera Therapeutics is a Cambridge, Massachusetts-based company.
1
Funding Rounds
$55.0m
Money raised
ScienceMachine is a London-based biotech AI startup launching an autonomous agent ('Sam') to streamline biomedical data analysis and visualization for pharma and biotech firms. Founded in 2024, it recently secured $3.5M in seed funding from Revent and Nucleus Capital.
1
Funding Rounds
$305.0m
Money raised
Parabilis Medicines is a Cambridge, Massachusetts-based company founded by Greg Verdine.
1
Funding Rounds
$47.5m
Money raised
1
Funding Rounds
$28.0m
Money raised
LPOXY Therapeutics is a Platte City, Missouri-based biopharmaceuticals company founded by Larry D. Sutton.
1
Funding Rounds
$50.0m
Money raised
Prolium Bioscience is a New York City-based company.
Enter your email and get access to 71,000 + technology companies you can partner with.